A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer

NCT02448173 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

550

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage II Colon Cancer

Interventions

BIOLOGICAL: OncoVAX and Surgery
PROCEDURE: Surgery

Sponsor

Vaccinogen Inc